Citation Impact
Citing Papers
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
Optimal Dissociation Methods Differ for N - and O -Glycopeptides
2020 StandoutNobel
Learning and reliability of colour Doppler ultrasound in giant cell arteritis.
2010
Incidence of giant cell arteritis in Western Norway 1972–2012: a retrospective cohort study
2017
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice
2018 Standout
Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study
2015
Down-Regulation of Na+/K+ATPase Activity by Human Parvovirus B19 Capsid Protein VP1
2013 Standout
EULAR recommendations for the management of primary small and medium vessel vasculitis
2008 Standout
The cutaneous manifestations of humanparvovirus B19 infection
2000
Genetically based resistance to the antiinflammatory effects of methotrexate in the air‐pouch model of acute inflammation
2005
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
2000
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Adjunctive methotrexate for treatment of giant cell arteritis: An individual patient data meta‐analysis
2007
The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease
2016
Rheumatoid arthritis
2018 Standout
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
2006 Standout
Adenosine: an endogenous regulator of innate immunity
2003
EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
2003 Standout
Tumor necrosis factor (TNF)α and its soluble receptor (sTNFR) p75 during acute human parvovirus B19 infection in children
2003
Methotrexate modulates the kinetics of adenosine in humans in vivo
2005
Parvovirus-associated arthritis
2000
Human parvovirus B19 infection: its relationship with systemic lupus erythematosus
1999
Parvovirus B19 nonstructural (NS1) protein as a transactivator of interleukin‐6 synthesis: Common pathway in inflammatory sequelae of human parvovirus infections?
2002
The epidemiology of biopsy-positive giant cell arteritis: special reference to cyclic fluctuations
1999
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis
2009 Standout
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
2010
Methotrexate for Inflammatory Bowel Disease: Pharmacology and Preliminary Results
1996
Pathogenesis of human parvovirus B19 in rheumatic disease
2000
EPIDEMIOLOGY OF THE VASCULITIDES
2001
Molecular action of methotrexate in inflammatory diseases.
2002
Hydroxychloroquine: From Malaria to Autoimmunity
2011 Standout
The antiinflammatory mechanism of methotrexate. Increased adenosine release at inflamed sites diminishes leukocyte accumulation in an in vivo model of inflammation.
1993
Juvenile idiopathic arthritis
2007 Standout
Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period
2001
Exercise Standards for Testing and Training
2013 Standout
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Adenosine receptors as therapeutic targets
2006 Standout
The Erythrocyte Sedimentation Rate Is Associated with the Development of Visual Complications in Biopsy-Proven Giant Cell Arteritis
2008
BSR and BHPR guidelines for the management of giant cell arteritis
2010
Glucocorticoid therapy in giant cell arteritis: Duration and adverse outcomes
2003
Coronary and valvular syndromes and antiphospholipid antibodies
2004
Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment
2014 Standout
Nonresolving Inflammation
2010 Standout
Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis
2007
Parvovirus B19 infection and autoimmune disease
2003
Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis
2011
EULAR recommendations for the management of large vessel vasculitis
2008
The hallucinating brain: A review of structural and functional neuroimaging studies of hallucinations
2007 Standout
Clinical features of polymyalgia rheumatica and giant cell arteritis
2012
Clinical relevance of persistently elevated circulating cytokines (tumor necrosis factor α and interleukin‐6) in the long‐term followup of patients with giant cell arteritis
2010
Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3receptor activation in thioglycollate-induced peritonitis
2006
Risk factors for visual loss in an Italian population‐based cohort of patients with giant cell arteritis
2005
Myocarditis
2011 Standout
Tocilizumab for induction and maintenance of remission in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
2016
Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register
2005
Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer
2007 Standout
EULAR evidence-based recommendations on the management of systemic glucocorticoid therapy in rheumatic diseases
2007
Diagnostic accuracy of dual-energy computed tomography in patients with gout: A meta-analysis
2017
Adenosine receptors: therapeutic aspects for inflammatory and immune diseases
2008 Standout
Atherosclerosis
2019 Standout
Non-motor features of Parkinson disease
2017 Standout
Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty‐year period
2004
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Polymyalgia Rheumatica and Giant-Cell Arteritis
2002 Standout
Visual symptoms in Parkinson's disease and Parkinson's disease dementia
2011
Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990–2001
2006
A Pragmatic Guide to Enrichment Strategies for Mass Spectrometry–Based Glycoproteomics
2020 StandoutNobel
Immune-mediated mechanisms of atherosclerosis and implications for the clinic
2016
2‐Chloroadenosine but not adenosine induces apoptosis in rheumatoid fibroblasts independently of cell surface adenosine receptor signalling
2002 StandoutNobel
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
2010 Standout
BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis
2007
Recent advances in the clinical management of giant cell arteritis and Takayasu arteritis
2016
Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis
2007
Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis
1999
Treatment of giant cell arteritis using induction therapy with high‐dose glucocorticoids: A double‐blind, placebo‐controlled, randomized prospective clinical trial
2006
Giant Cell Arteritis: Epidemiology, Diagnosis, and Management
2010
Parvovirus B19
2004 Standout
Management of Crohn's Disease in Adults
2009 Standout
Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations
2005
How much warfarin is enough in APS related thrombosis?
2004
Inflammatory bone loss: pathogenesis and therapeutic intervention
2012 Standout
Human parvovirus B19 non-structural protein (NS1) induces apoptosis through mitochondria cell death pathway in COS-7 cells
2004
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
Myocarditis
2009 Standout
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Physiology and Pathophysiology of Carnosine
2013 Standout
Duplex sonography of the temporal and occipital artery in the diagnosis of temporal arteritis. A prospective study.
2003
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist
2017
Methotrexate inhibits neutrophil function by stimulating adenosine release from connective tissue cells.
1991
Giant Cell Arteritis: A Systematic Review of the Qualitative and Semiquantitative Methods to Assess Vasculitis with 18F-Fluorodeoxyglucose Positron Emission Tomography
2014
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the Diagnosis and Management of Patients With Thoracic Aortic Disease
2010 Standout
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Giant-Cell Arteritis and Polymyalgia Rheumatica
2003
Magnesium in Man: Implications for Health and Disease
2014 Standout
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.
2007
The Role of Ultrasound Compared to Biopsy of Temporal Arteries in the Diagnosis and Treatment of Giant Cell Arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study
2016
Temporal Artery Compression Sign - A Novel Ultrasound Finding for the Diagnosis of Giant Cell Arteritis
2012
Cell surface expression of intermediate filament proteins vimentin and lamin B1 in human neutrophil spontaneous apoptosis
2005
Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection
2005
Giant Cell Arteritis versus Takayasu Arteritis: An Update
2020
Human Parvovirus B19
2002 Standout
Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis
2016
Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
2003
Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate
2003
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death
2006
Multilayered N-Glycoproteome Profiling Reveals Highly Heterogeneous and Dysregulated Protein N-Glycosylation Related to Alzheimer’s Disease
2019
False positives in the ultrasound diagnosis of giant cell arteritis: some diseases can also show the halo sign
2019
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Update on Spondyloarthropathies
2002
Loss of TET proteins in regulatory T cells promotes abnormal proliferation, Foxp3 destabilization and IL-17 expression
2019 StandoutNobel
Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon
2012 StandoutNobel
Food allergy: a practice parameter
2006
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis.
2010
Human Parvovirus B19 Infection Resembling Systemic Lupus Erythematosus.
1998
Gout
2021 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis
2015
Facial nerve injury during temporal artery biopsy
2014
Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of Comorbidities
2014
N-Glycosylation of Carnosinase Influences Protein Secretion and Enzyme Activity
2010
The VP1 Unique Region of Parvovirus B19 and Its Constituent Phospholipase A2-Like Activity
2002
Effectiveness of Manual Physical Therapy and Exercise in Osteoarthritis of the Knee
2000
Induction of Clinical Autoimmune Disease by Therapeutic Interferon-α
2003
The Continuing Challenges of Leprosy
2006 Standout
Incidence of Severe Infections and Infection‐Related Mortality During the Course of Giant Cell Arteritis: A Multicenter, Prospective, Double‐Cohort Study
2016
Works of Gideon Nesher being referenced
In vitro effects of methotrexate on peripheral blood monocytes: modulation by folinic acid and S-adenosylmethionine.
1991
The diagnosis and classification of giant cell arteritis
2014
Risk Factors for Cranial Ischemic Complications in Giant Cell Arteritis
2004
Alpha-interferon-induced arthritis: clinical presentation, treatment, and prevention
1998
The in vitro effects of methotrexate on peripheral blood mononuclear cells: Modulation by methyl donors and spermidine
1990
Dolichol-Mediated Enhanced Protein N-Glycosylation in Experimental Diabetes— A Possible Additional Deleterious Effect of Hyperglycemia
1997
Parvovirus infection mimicking systemiclupus erythematosus
1995
Charles Bonnet Syndrome in Glaucoma Patients With Low Vision
2001
Anti-nuclear envelope antibodies: Clinical associations
2001
The Incidence of Primary Systemic Vasculitis in Jerusalem: A 20-year Hospital-based Retrospective Study
2016
GIANT CELL ARTERITIS IN JERUSALEM: A 12-YEAR EPIDEMIOLOGICAL STUDY
1994
Valvular dysfunction in antiphospholipid syndrome: Prevalence, clinical features, and treatment
1997
Parvovirus infection mimicking systemic lupus erythematosusin a pediatric population
1999
Recurrent Ventricular Tachycardia in Hypothyroidism -Report of a Case and Review of the Literature
1988
Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update
2016
The fine line between Takayasu arteritis and giant cell arteritis
2014
Rate of Discordant Findings in Bilateral Temporal Artery Biopsy to Diagnose Giant Cell Arteritis
2009
Steroid-sparing medications in temporal arteritis — Report of three cases and review of 174 reported patients
1994
Effect of caffeine consumption on efficacy of methotrexate in rheumatoid arthritis
2003
Low‐dose aspirin and prevention of cranial ischemic complications in giant cell arteritis
2004
[Quinines--past and present].
2007
Perceived efficacy among patients of various methods of complementary alternative medicine for rheumatologic diseases.
2005
Clinical Presentation and Treatment of Arthritis in the Aged
1994
The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations.
2007
Giant cell arteritis and polymyalgia rheumatica: clues to early diagnosis.
1997
Palindromic rheumatism: effect of dietary manipulation.
2000
The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis.
2002
In vitro effects of methotrexate on polyamine levels in lymphocytes from rheumatoid arthritis patients.
1997
Visual hallucinations in giant cell arteritis: association with visual loss.
2001
Analysis of steroid related complications and mortality in temporal arteritis: a 15-year survey of 43 patients.
1994
Bacillus Calmette-Guérin induced reactive arthritis.
1999
Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease.
2009
Efficacy and adverse effects of different corticosteroid dose regimens in temporal arteritis: a retrospective study.
1997
Dual‐energy computed tomography as a diagnostic tool for gout during intercritical periods
2016
Effect of biopsy length on the rate of positive temporal artery biopsies.
2010
Antiperinuclear factor in juvenile rheumatoid arthritis.
1992
Effect of treatment with methotrexate, hydroxychloroquine, and prednisone on lymphocyte polyamine levels in rheumatoid arthritis: correlation with the clinical response and rheumatoid factor synthesis.
1997